Patent US3609259A successfully refreshed from Google Patents.
Patent US5219752A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5219752A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for continuously culturing adherent animal cells

Assignee: Teijin Ltd
•
Filing: 1991-07-15
•
Granted: 1993-06-15
•
Expires: 2011-07-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Adherent 293 human kidney cells are continuously cultured in suspension in serum-free medium. Fresh medium is fed into a culture vessel and spent medium is withdrawn from the vessel. The 293 cells are maintained in small aggregates in suspension at a density of at least 3x106 cells/ml for 30 days. The formation of large cell clumps is prevented by maintaining the concentration of calcium in the serum-free medium at 0.002 mM to 0.3 mM.

Inventors

  • 👤 Yoshiharu Takazawa
  • 👤 Michiyuki Tokashiki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:22
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/0018; C12N5/0037; C12N2500/00; C12N2500/05; C12N2500/10; C12N2500/12; C12N2500/14; C12N2500/20; C12N2500/24; C12N2500/25

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 128 words
A process for continuously culturing adherent animal cells selected from the group consisting of 293 strain derived from human fetal kidney cells and tranformants thereof, which cells are capable of secreting protein C in a serum-free medium, comprising: feeding fresh medium into a culture vessel, and withdrawing spent medium from the vessel, maintaining the said adherent animal cells in the serum-free medium in the said vessel in suspension, the said adherent animal cells being maintained in suspension at a density of at least 3×10 6 cells/ml, the concentration of calcium ion in the medium under the culturing conditions being maintained at 0.002 mM to 0.3 mM, and the protein C production level being at least 0.1 μg/10 6 cell/day for a period of about 30 days or longer.
Claim 2
Dependent Claim 128 words
A process for continuously culturing adherent animal cells selected from the group consisting of 293 strain derived from human fetal kidney cells and tranformants thereof, which cells are capable of secreting protein C in a serum-free medium, comprising: feeding fresh medium into a culture vessel, and withdrawing spent medium from the vessel, maintaining the said adherent animal cells in the serum-free medium in the said vessel in suspension, the said adherent animal cells being maintained in suspension at a density of at least 3×10 6 cells/ml, the concentration of calcium ion in the medium under the culturing conditions being maintained at 0.002 mM to 0.3 mM, and the protein C production level being at least 0.1 μg/10 6 cell/day for a period of about 30 days or longer.
Claim 3
Dependent Claim 27 words
The process of claim 1 in which the concentration of a calcium ion in the medium under the culturing conditions is maintained 0.002 mM to 0.25 mM.
Claim 4
Dependent Claim 31 words
The process of claim 1 or 2 in which most of the adherent animal cells in suspension are present as aggregated particles each containing 1.5 to 50 cells on an average.
Claim 5
Dependent Claim 31 words
The process of claim 1 or 2 in which most of the adherent animal cells in suspension are present as aggregated particles each containing 1.5 to 30 cells on an average.
Claim 6
Dependent Claim 24 words
The process of claim 1 in which the adherent animal cells in suspension are present at a density of at least 5×10 6 cells/ml.
Claim 7
Dependent Claim 44 words
The process of claim 1 in which the feeding of the fresh medium, and the withdrawal of the spent medium, into and from the culture vessel are carried out continuously or intermittently, and the liquid level in the culture vessel is maintained substantially constant.
Claim 8
Dependent Claim 25 words
The process of claim 1 in which the suspended state of the adherent animal cells in the culture vessel is maintained by agitation and/or aeration.

References Cited (Backward Citations)

US4059485A Cited
US4184916A Cited
US4560655A Cited
US5114855A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-06-14 1996-12-14 1997-06-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-06-14 2000-12-14 2001-06-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-06-14 2004-12-14 2005-06-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag